Abbreviations {#nomen0010}
=============

ATT

:   Adipose tissue thickness

BMI

:   Body mass index

CEPL

:   Clinical exercise performance laboratory

CHF

:   Chronic heart failure

COPD

:   Chronic obstructive pulmonary disease

FiO2

:   Inspiratory oxygen fraction

MRT

:   Mean response time

NIRS

:   Near infra-red spectroscopy

PCr

:   Phosphocreatine

R2

:   Coefficient of determination

Rpm

:   Revolutions per minute

τ

:   Time constant

Td

:   Time delay

tHb

:   Total blood volume in the muscle

TSI

:   Tissue saturation index

VO~2~

:   Oxygen uptake

VO~2peak~

:   Peak oxygen uptake

Wmax

:   Maximal workload

1. Introduction {#sec1}
===============

The rate of change of pulmonary oxygen uptake (VO~2~) following an acute bout of submaximal exercise, also defined as VO~2~ offset kinetics, reflects the ability of an individual to recover from exercise.[@bib1], [@bib2] Changes in cardiac output as well as the balance between oxygen delivery and utilization in activated muscle tissue are the main contributing factors influencing oxygen uptake kinetics. Slower recovery kinetics in patients with an impaired cardiovascular function appear to represent an oxygen delivery limitation,[@bib3] either due to impaired blood flow and/or endothelial dysfunction of the microvasculature in skeletal muscle.[@bib3], [@bib4] Furthermore, VO~2~ offset kinetics have been shown a sensitive and reproducible[@bib5] measure to detect oxygen delivery limitations under hypoxic conditions[@bib1] Although the concept of VO~2~ offset kinetics was first introduced in clinical exercise physiology about 3 decades ago,[@bib6] its diagnostic application to assess the physiological mechanisms underlying exercise intolerance under normoxic conditions is still limited. Previous research suggests that the systemic relationship between oxygen delivery and consumption could potentially be determined by simultaneously measuring pulmonary and muscle tissue oxygen levels following manipulation of inspiratory oxygen fraction (FiO~2~).[@bib7], [@bib8] If, for instance, hyperoxia would simultaneously improve pulmonary and muscle oxygen uptake kinetics, oxygen delivery to the muscle is most likely the rate-limiting step for oxygen utilization in muscle tissue. The present study aimed to investigate whether combined non-invasive measurements of pulmonary and muscle tissue oxygen uptake kinetics under manipulated FiO2 conditions, can be used as a novel physiological assessment tool to challenge the respiratory and microvascular system and potentially differentiate peripheral from central oxygen uptake limitations in healthy subjects. Based on the available research and our current understanding of oxygen uptake kinetics,[@bib1], [@bib4], [@bib6], [@bib9], [@bib10], [@bib11] we hypothesized that in healthy moderately trained subjects, acute exposure to hyperoxia would not improve muscle tissue oxygen uptake recovery kinetics, while acute exposure to hypoxia would impair the recovery kinetics.

2. Methods {#sec2}
==========

2.1. Subjects {#sec2.1}
-------------

Sixteen healthy, young adults (BMI: 22.0 ± 1.5kg/m^2^, (22 ± 2 yrs)) were recruited through social media at Erasmus University Medical Centre in Rotterdam, the Netherlands and agreed to participate in the study ([Table 1](#tbl1){ref-type="table"}). There were no gender differences in any of the variables measured. The study protocol, which was a sub study of a larger clinical trial on optimization of exercise therapy in type 2 diabetes patients, was approved by the regional Medical Ethics Committee of the Erasmus University Medical Centre in Rotterdam, the Netherlands (MEC; number: 2012-128; and registered at the Dutch Trial Registry number: NTR3777.Table 1Subjects\' characteristics.Table 1n = 16 (10 male and 6 female)Mean ± SDAge (years)22.3 ± 2.4Weight (kg)77.4 ± 11.9Height (cm)183 ± 9BMI (kg/m^2^)23.0 ± 2.3VO~2peak~ (ml/min/kg)45.6 ± 8.8Wmax (Watt)315.2 ± 63.0ATT (mm)6.1 ± 3Borg Score16.3 ± 0.8[^1]

2.2. Experimental protocol {#sec2.2}
--------------------------

Subjects visited the Clinical Exercise Performance Laboratory (CEPL) four times. An interview, physical examination and all exercise tests (1 maximal + 3 submaximal tests) were at the Erasmus University Medical Center in Rotterdam, the Netherlands within a time frame of 4 weeks. During the first appointment a sports physician performed an interview and physical examination. To assess maximal workload (W~max~) and maximal oxygen uptake (VO~2peak~) subjects were asked to perform a standard incremental exercise test on a cycle ergometer (protocols: ramp 120 (2 Watt/10 seconds) for women and a ramp 180 (3 Watt/second) for men). Perceived exertion level after the incremental exercise test was rated using a Borg Scale.[@bib12] The subjects breathed the oxygen mixtures through the entire protocol including rest, exercise and recovery.

2.3. Blinding procedure {#sec2.3}
-----------------------

During the next three visits (with 7 days washout periods) participants underwent a sub-maximal exercise test under various inspiratory fractions of oxygen (FiO~2~) 14%, 21% and 35% O~2~ (BOC Morden, London, UK). These levels of FiO~2~ were considered safe during maximal exercise tests.[@bib13] The subjects were blinded to the randomized order of FiO~2~ during the submaximal tests by drawing an opaque sealed envelope. The sub-maximal exercise test protocol was as follows: 10 minutes of rest, 3 minutes of unloaded cycling, 6 minutes of cycling at 40% of their W~max~ and 5 minutes of recovery. Subjects were instructed to maintain cadence between 60 and 80 revolutions per minute (rpm).

2.4. Medical gasses {#sec2.4}
-------------------

Each test was performed under either mixture of 14%, 21% and 35% of oxygen in nitrogen - 50 liter cylinders (BOC Morden, London, UK). The control oxygen conditions (21% of oxygen in nitrogen) were ordered and prepared in the EMC and delivered to the CEPL by the internal medical gasses distributor (Linde Gas, The Netherlands). The air was inspired from a cylinder through a Douglas bag (20 liter) connected to an oro-nasal 7400 Vmask™ and a 2730 2-way Y-shape™ non-rebreathing two-way valve (Hans Rudolph, inc. Kansas, USA).

2.5. Respiratory gas measurements {#sec2.5}
---------------------------------

The analysis of oxygen uptake (VO~2~) and production of carbon dioxide (VCO~2~) levels were continuously measured through a metabolic cart (Oxycon Pro, Jaeger, Mannheim, Germany).

2.6. NIRS measurements {#sec2.6}
----------------------

The methodology of the NIRS (Portamon, The Netherlands) measurement procedures as well as data collection of an absolute measure of tissue oxygen saturation (tissue saturation index (TSI), have been described elsewhere.[@bib14] Given the thickness of the subcutaneous adipose tissue may confound the NIRS signal amplitude, the skinfold thickness was measured and reported. Skinfold thickness of the m. vastus lateralis at the site of the NIRS device was measured (median of three measurements) in seated position using Harpenden skinfold callipers (British Indicators Ltd, Burgess Hill, UK). Adipose tissue thickness was calculated by dividing skinfold thickness by two,[@bib15] resembling subcutaneous fat and skin. (ATT).

2.7. Absolute values {#sec2.7}
--------------------

The methodology of calculating all VO~2~ and TSI absolute values (amplitude, baseline and steady-state) were described in detail in a reproducibility study of Niemeijer et al. (Niemeijer et al., 2015).

2.8. Pulmonary VO~2~ kinetics {#sec2.8}
-----------------------------

Fitting of mono-exponential curves of onset and offset oxygen uptake kinetics was performed in Python 2.7 (Python Software Foundation), in order to calculate the time constant and increase in oxygen uptake. Two formulas were used for offset kinetics, as described before.[@bib16]B = VO~2~-amplitude during exercise (ml/min), Td = time delay (s) and τ = time constant tau (s).

2.9. NIRS kinetics analysis {#sec2.9}
---------------------------

Time constants (τ) of recovery were calculated by fitting the TSI data to a first-order.

(mono-exponential) model using the non-linear least squares method (Python 2.7, Python Software Foundation). Additionally, the mean response time (MRT) was calculated as the sum of tau and time delay (MRT = τ + T~d~). Considering better reproducibility, we used MRT TSI for the kinetics comparisons with tau VO~2~. The coefficient of determination (r^2^) was applied to determine how well the fitted mono-exponential curve approximated the real data points. r^2^ ranges from 0 to 1 with 1 as an indicator for a line that perfectly fits the real data. The methodological details of the recovery TSI kinetics are available elsewhere (Niemeijer et al., 2015). All calculations were adjusted for FiO~2~.

2.10. Statistical analysis {#sec2.10}
--------------------------

Subject' characteristics were expressed as mean ± SD. The obtained results under the three oxygen conditions were compared using a General Linear Model with repeated measures (IBM SPSS Statistics version 20). Level of significance was set at p \< 0.05. The Bonferroni post-hoc analysis was used in multiple comparisons.

3. Results {#sec3}
==========

3.1. VO~2~ kinetics {#sec3.1}
-------------------

Curve fitting levels of VO~2~ offset kinetics were sufficiently accurate for hypoxia (r^2^ = 0.89 ± 0.07), normoxia (r^2^ = 0.92 ± 0.04) and hyperoxia (r^2^ = 0.92 ± 0.04). The τ of VO~2~ offset kinetics under hypoxic conditions was respectively 7 ± 9 and 8 ± 11 seconds larger than τ of the offset kinetics under normoxia (p = 0.02) and hyperoxia (p = 0.04) ([Table 2](#tbl2){ref-type="table"}). However, there was no significant difference in τ between normoxic and hyperoxic conditions ([Table 2](#tbl2){ref-type="table"}).Table 2Mean τ values of VO~2~ and TSI offset kinetics under hypoxic, normoxic and hyperoxic conditions.Table 2HypoxiaNormoxiaHyperoxiaP-valueOffset kineticsτ ~VO2~ (s)44.9 ± 7.337.9 ± 8.2\*37 ± 6\*\*0.02\*; 0.04\*\*MRT ~TSI~ (s)25.5 ± 13.015.0 ± 7.7\*13.0 ± 7.3\*\*0.007\*; 0.008\*\*[^2]

3.2. TSI kinetics {#sec3.2}
-----------------

Monoexponential curve fitting was sufficiently accurate for hypoxia (r^2^ = 0.97 ± 0.02), normoxia (r^2^ = 0.93 ± 0.06) and hyperoxia (r^2^ = 0.90 ± 0.11). The MRT of TSI offset kinetics under hypoxic conditions was respectively 10 ± 11 and 12 ± 13 seconds longer than MRT of the offset kinetics under normoxia (p = 0.007) and hyperoxia (p = 0.008) ([Table 2](#tbl2){ref-type="table"}). Hyperoxic conditions did not accelerate the offset kinetics. The τ values of VO~2~ offset kinetics were significantly larger than MRT of TSI (p = 0.0001) under the different oxygen conditions ([Table 2](#tbl2){ref-type="table"}).

3.3. Absolute baseline and steady-state values of VO~2~ and TSI {#sec3.3}
---------------------------------------------------------------

The absolute steady-state values of VO~2~ were not different in normoxia (VO~2~ p = 1.0) and hyperoxia (VO~2~ p = 1.0) as compared to hypoxia. Only the absolute steady-state values of TSI were significantly different in hypoxia compared with normoxia (p = 0.0001) and hyperoxia (p = 0.003). TSI amplitude values were significantly different between normoxia and hyperoxia (p = 0.01) and normoxia and hypoxia (p = 0.001) ([Table 3](#tbl3){ref-type="table"}). Additionally, there was no difference (p = 1.00) in amplitude of total blood volume in the muscle (tHb) between the FiO~2~ conditions.Table 3Mean baseline (rest) and steady-state absolute values of VO~2~ and TSI under hypoxic, normoxic and hyperoxic conditions.Table 3HypoxiaNormoxiaHyperoxiaP-valueBaselineVO~2~ (ml/kg/min)2.9 ± 0,43.0 ± 0.5\*3.2 ± 0.5\*\*0.06\*; 0.8\*\*TSI (%)67.2 ± 5,368.4 ± 4.8\*70.8 ± 7.8\*\*0.8\*; 0.3\*\*tHb (μM_cm)118.6 ± 38.9115.1 ± 39.1\*115.5 ± 37.8\*\*0.4\*; 0.68\*\*Steady-stateVO~2~ (ml/kg/min)20 ± 3.119 ± 2.9\*18.9 ± 2.9\*\*1.0\*; 1.0\*\*TSI (%)**60.3 ± 7,665.4 ± 6\*66.1 ± 8.9\*\*0.0001\*; 0.003\*\***tHb (μM_cm)109.7 ± 36.4106.4 ± 36.1\*106.7 ± 34.8\*\*0.28\*; 0.56\*\*Amplitude of RecoveryVO~2~ (ml/kg/min)15.6 ± 2,415.3 ± 2.4\*15.4 ± 2.4\*\*1.0\*; 1.0\*\*TSI (%)**9.7 ± 56.4 ± 4.1\*5.8 ± 2.7\*\*0.001\*; 0.01\*\***tHb (μM_cm)-8.8 ± 4.5-8.7 ± 4.4\*-8.7 ± 5.9\*\*1.0\*; 1.0\*\*[^3]

4. Discussion {#sec4}
=============

In the present study we investigated whether higher FiO~2~ can improve oxygen uptake recovery kinetics following a constant-load submaximal bout of exercise. In line with our hypothesis, the main finding of this study was that higher FiO~2~ conditions did not accelerate the recovery kinetics in healthy young participants without any clinical signs of oxygen uptake or oxygen delivery limitations. Nevertheless, lower FiO~2~ significantly impaired oxygen uptake recovery kinetics in these individuals.

To date, it is still equivocal whether additional oxygen in inspired air can be beneficial in improving oxygen uptake recovery kinetics and submaximal exercise tolerance[@bib17] in either healthy or diseased populations. The effect of the higher FiO~2~ on the recovery kinetics rate may both depend on cardiovascular function[@bib18] as well as individual sensitivity to manipulated FiO~2~ conditions.[@bib19] In our population of healthy participants, we did not find any obvious beneficial effects of acute exposure to hyperoxia on either VO~2~ uptake or muscle oxygenation recovery kinetics ([Table 2](#tbl2){ref-type="table"}). As such, our results extend on the work from Macdonald et al. by showing that muscle oxygenation recovery kinetics can provide further insights into the peripheral effects of hyperoxic exercise. In the study of Macdonald et al. participants performed submaximal exercise tests below the ventilatory threshold in normoxia and hyperoxia (70% O~2~). Similar to 35% of oxygen in the present study, even those higher levels of hyperoxia have no additional effects on VO~2~ offset kinetics.[@bib20] Grassi et al. suggest that muscle oxygen kinetics are closely related to pulmonary oxygen uptake kinetics.[@bib7] Indeed, our results show proportional changes of muscle oxygenation and pulmonary VO~2~ under manipulated FiO2 ([Table 2](#tbl2){ref-type="table"}), which extends on the results of Macdonald et al. using VO~2~ uptake kinetics, only. Rossiter et al. have shown that muscle oxygenation rate was correlated with the recovery kinetics of phosphocreatine following a submaximal exercise bout.[@bib21] The present study indicates that assessment of peripheral recovery kinetics through NIRS can potentially be a more simple and cost-effective method than the use of a metabolic cart system. Similar hyperoxic exercise studies in patients with clinically relevant impairments in the cardiovascular[@bib5] and/or pulmonary[@bib22] system are required to compare and validate NIRS-based TSI with VO~2~ uptake recovery kinetics following hyperoxic submaximal exercise.

In order to investigate the sensitivity of NIRS and VO~2~ measurements we investigated VO~2~ and TSI offset kinetics under hypoxic conditions as a model to induce an artificial oxygen delivery limitation in healthy subjects. In line with previous work in this area,[@bib1] we found slower oxygen uptake and muscle oxygenation kinetics ([Table 2](#tbl2){ref-type="table"}). Slower recovery kinetics under lower FiO~2~ conditions may suggest a blunted compensatory hyperemic vasodilatory response (decreased blood volume)[@bib4] in older/diseased subjects.[@bib23] In our study there was no difference in the amplitude of tHb (related to blood flow) between the FiO~2~ conditions. This suggests that there was no need for compensatory vasodilation to increase oxygen delivery under hypoxic conditions. Taken together, slower TSI and VO~2~ recovery kinetics under hypoxic conditions indicate that both NIRS and spiro-ergometry are both appropriate non-invasive measurement tools to assess the physiological response of a healthy individual to hypoxic exercise. Its clinical relevance still needs to be established by similar NIRS-VO~2~ uptake recovery kinetic studies in patient populations with cardiovascular, pulmonary and/or metabolic induced exercise intolerance.

Variability of the mono-exponential curve fitting technique as used in the current study was a limitation. In particular, hyperoxic condition data points were harder to fit by a mono-exponential technique but it was still reasonably good (certainly when compared with pulmonary oxygen kinetics). The reason for this could be an altered vascular/metabolic response, which is not mono-exponential.

In conclusion, the present study shows that there was no improvement in the oxygen uptake and muscle oxygenation recovery kinetics in healthy subjects under hyperoxic conditions. Future studies should focus on mechanisms of tolerance to altered FiO~2~ conditions (vascular/metabolic) and finding a principal limitation to recovery from moderate-intensity exercise forms. Furthermore, the present study suggests that NIRS based recovery kinetics could potentially replace VO~2~ uptake kinetics as measured through a metabolic cart. As such, NIRS could be useful when assessing an individual\'s response to field-based submaximal exercise conditions mimicking average daily life activities and work conditions in health and disease.
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[^1]: BMI Body Mass Index; VO~2~ peak maximum oxygen uptake; ATT adipose tissue thickness.

[^2]: Amount of '\*' assigns the statistical difference between FiO2 conditions (\*-hypoxia with normoxia and \*\*-hypoxia with hyperoxia and \*\*\*-normoxia with hyperoxia) to a p-value.

[^3]: Amount of '\*' assigns the statistical difference between FiO2 conditions (\*-hypoxia with normoxia and \*\*-hypoxia with hyperoxia) to a p-value. The bold values signifies p \< 0.05.
